VRTX
Companies
NASDAQ
Vertex Pharmaceuticals Inc.
Health Care
$448.40
+$45.70 (+11.35%)
Price Chart
Overview
About VRTX
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Market Cap
$124.7B
Volume
1.3B
Avg. Volume
930.6M
P/E Ratio
23.369738
Dividend Yield
0.00%
Employees
5.1K
Company Information
Latest News for VRTX
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
May 6, 2025
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 1, 2025
Final Trades: Vertex Pharma, Palantir, Wynn Resorts and Microsoft
May 9, 2025
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
June 19, 2025
Risk & Correlation Analysis
Market Correlation
0.36
Low Correlation
Volatility
Medium (0.27)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, VRTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$124.7B
Volume1.3B
P/E Ratio23.37
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 6, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025